298 related articles for article (PubMed ID: 17132062)
1. Intellectual property and access to ART: unwise choice of terminology.
Stallman R
PLoS Med; 2006 Nov; 3(11):e509; author reply e510. PubMed ID: 17132062
[No Abstract] [Full Text] [Related]
2. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar JM
Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
[No Abstract] [Full Text] [Related]
3. How do intellectual property law and international trade agreements affect access to antiretroviral therapy?
Westerhaus M; Castro A
PLoS Med; 2006 Aug; 3(8):e332. PubMed ID: 16881728
[TBL] [Abstract][Full Text] [Related]
4. Essential drugs in the new international economic environment.
Velásquez G; Boulet P
Bull World Health Organ; 1999; 77(3):288-92. PubMed ID: 10212525
[TBL] [Abstract][Full Text] [Related]
5. Patents & public health: international trade obligations and domestic policy development.
Amani B
Health Law Can; 2002 Feb; 22(3):76-84. PubMed ID: 11915591
[No Abstract] [Full Text] [Related]
6. Essential AIDS medications in India.
Thomas J
Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
[No Abstract] [Full Text] [Related]
7. [HIV antiretroviral agents: new threats to accessibility in developing countries].
Nau JY
Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
[No Abstract] [Full Text] [Related]
8. International patent law-boon or bane of biotech?
Basu P
Nat Biotechnol; 2005 Jan; 23(1):13-5. PubMed ID: 15637604
[No Abstract] [Full Text] [Related]
9. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals.
Correa CM
Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300
[No Abstract] [Full Text] [Related]
10. USA-Morocco deal may extend drug patents to 30 years.
Ahmad K
Lancet; 2003 Dec; 362(9399):1904. PubMed ID: 14672079
[No Abstract] [Full Text] [Related]
11. International panel considers global patent system needs reassessment.
Ashraf H
Lancet; 2002 Sep; 360(9336):858. PubMed ID: 12243929
[No Abstract] [Full Text] [Related]
12. Practical strategies to combat biopiracy.
Lawrence S; Skordis J
Lancet; 2004 Jan; 363(9403):166. PubMed ID: 14726178
[No Abstract] [Full Text] [Related]
13. Straight talk with...Ellen 't Hoen.
Mullard A
Nat Med; 2010 Dec; 16(12):1351. PubMed ID: 21135826
[TBL] [Abstract][Full Text] [Related]
14. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand.
Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P
Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042
[TBL] [Abstract][Full Text] [Related]
15. Intellectual property under GATT.
Nature; 1993 Dec; 366(6456):587-8. PubMed ID: 8259195
[No Abstract] [Full Text] [Related]
16. Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad.
Luo J; Kesselheim AS
AMA J Ethics; 2016 Jul; 18(7):727-35. PubMed ID: 27437823
[TBL] [Abstract][Full Text] [Related]
17. Patents versus patients? Antiretroviral therapy in India.
Havlir DV; Hammer SM
N Engl J Med; 2005 Aug; 353(8):749-51. PubMed ID: 16120852
[No Abstract] [Full Text] [Related]
18. Access to generic antiretrovirals: inequality, intellectual property law, and international trade agreements.
Castro A; Westerhaus M
Cad Saude Publica; 2007; 23 Suppl 1():S85-96. PubMed ID: 17308722
[TBL] [Abstract][Full Text] [Related]
19. The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines.
Luo J; Kesselheim AS
JAMA; 2015 Oct; 314(15):1563-4. PubMed ID: 26291894
[No Abstract] [Full Text] [Related]
20. The Supreme Court's war on intellectual property.
Gardner JN
Nat Biotechnol; 2000 Jan; 18(1):101-2. PubMed ID: 10625402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
